DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $732,391 | +4.4% | 2,952 | +1.0% | 0.04% | +10.0% |
Q2 2023 | $701,520 | +0.2% | 2,923 | +5.3% | 0.04% | -7.0% |
Q1 2023 | $699,915 | -5.0% | 2,777 | 0.0% | 0.04% | -8.5% |
Q4 2022 | $737,071 | +2.8% | 2,777 | 0.0% | 0.05% | -2.1% |
Q3 2022 | $717,000 | +1.8% | 2,777 | 0.0% | 0.05% | +9.1% |
Q2 2022 | $704,000 | -13.6% | 2,777 | 0.0% | 0.04% | 0.0% |
Q1 2022 | $815,000 | -10.8% | 2,777 | 0.0% | 0.04% | -2.2% |
Q4 2021 | $914,000 | +6.8% | 2,777 | -1.2% | 0.04% | -2.2% |
Q3 2021 | $856,000 | +28.0% | 2,812 | +12.8% | 0.05% | +27.8% |
Q2 2021 | $669,000 | +19.3% | 2,492 | 0.0% | 0.04% | +12.5% |
Q1 2021 | $561,000 | +57.1% | 2,492 | +55.1% | 0.03% | +52.4% |
Q4 2020 | $357,000 | +3.2% | 1,607 | 0.0% | 0.02% | -8.7% |
Q3 2020 | $346,000 | +21.8% | 1,607 | 0.0% | 0.02% | +9.5% |
Q2 2020 | $284,000 | +27.9% | 1,607 | 0.0% | 0.02% | +10.5% |
Q1 2020 | $222,000 | -10.1% | 1,607 | 0.0% | 0.02% | +18.8% |
Q4 2019 | $247,000 | +6.5% | 1,607 | 0.0% | 0.02% | -5.9% |
Q3 2019 | $232,000 | +0.9% | 1,607 | 0.0% | 0.02% | 0.0% |
Q2 2019 | $230,000 | +8.5% | 1,607 | 0.0% | 0.02% | +6.2% |
Q1 2019 | $212,000 | – | 1,607 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |